Panagora Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 125,891 shares of ALNY stock, worth $30.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

125,891

Previous 19,810 535.49%

Holding current value

$30.7 Million

Previous $4.81 Million 619.51%

% of portfolio

0.17%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $24.8 Million - $30.4 Million	106,081 Added 535.49%	125,891 $34.6 Million
Q2 2024 Jul 29, 2024	BUY	$143.31 - $247.0 $1.77 Million - $3.05 Million	12,353 Added 165.66%	19,810 $4.81 Million
Q3 2023 Oct 31, 2023	BUY	$170.77 - $211.65 $398,918 - $494,414	2,336 Added 45.62%	7,457 $1.32 Million
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $27,764 - $35,800	-152 Reduced 2.88%	5,121 $1.03 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $200,186 - $260,373	-1,079 Reduced 16.99%	5,273 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $29,509 - $49,416	-213 Reduced 3.24%	6,352 $1.27 Million
Q1 2022 May 12, 2022	BUY	$127.18 - $173.91 $409,901 - $560,511	3,223 Added 96.44%	6,565 $1.07 Million
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $425,546 - $558,176	-2,667 Reduced 44.38%	3,342 $567,000
Q2 2021 Aug 11, 2021	SELL	$128.63 - $176.89 $52,866 - $72,701	-411 Reduced 6.4%	6,009 $1.02 Million
Q1 2021 May 12, 2021	BUY	$126.83 - $175.69 $183,396 - $254,047	1,446 Added 29.07%	6,420 $906,000
Q4 2020 Feb 10, 2021	BUY	$122.97 - $147.0 $162,566 - $194,334	1,322 Added 36.2%	4,974 $646,000
Q2 2020 Aug 12, 2020	BUY	$104.21 - $156.44 $15,006 - $22,527	144 Added 4.1%	3,652 $541,000
Q4 2019 Feb 12, 2020	BUY	$74.51 - $124.23 $19,149 - $31,927	257 Added 7.91%	3,508 $404,000
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $49,559 - $61,386	-699 Reduced 17.7%	3,251 $261,000
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $52,969 - $68,031	-728 Reduced 15.56%	3,950 $369,000
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $36,599 - $51,584	584 Added 14.26%	4,678 $341,000
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $85,682 - $120,093	979 Added 31.43%	4,094 $358,000
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $32,763 - $39,993	371 Added 13.52%	3,115 $307,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $2,202 - $2,822	19 Added 0.7%	2,744 $327,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $197,644 - $322,285	2,725	2,725 $320,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History